Post-chemotherapy response of paclitaxel and carboplatin regimens in advanced stage cervical cancer types of histopathology squamous cell carcinoma and adenocarcinoma

yu, HARIADI

dc.contributor.author	yu, HARIADI
dc.date.accessioned	2024-09-09T03:21:58Z
dc.date.available	2024-09-09T03:21:58Z
dc.date.issued	2023-02-23
dc.identifier.issn	2302-2914
dc.identifier.uri	https://repo-dosen.ulm.ac.id//handle/123456789/36190
dc.description.abstract	Cervical cancer incidence in South Borneo was placed 10th in Indonesia. South Borneo Department of Health revealed 1,930 patients diagnosed with cervical cancer in 2019. The main therapy for advanced cervical cancer was radiotherapy, chemotherapy, and combination. This study aims to demonstrate that paclitaxel plus carboplatin regimens have a better post-chemotherapy response in patients with advanced cervical cancer squamous cell carcinoma than adenocarcinoma.	en_US
dc.language.iso	en	en_US
dc.publisher	Bali Medical Journal	en_US
dc.subject	Post-chemotherapy response, squamous cell carcinoma, adenocarcinoma	en_US
dc.title	Post-chemotherapy response of paclitaxel and carboplatin regimens in advanced stage cervical cancer types of histopathology squamous cell carcinoma and adenocarcinoma	en_US
dc.type	Article	en_US